{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:09:24Z","timestamp":1793286564836,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1378\/chest.126.3_suppl.609s","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:47:46Z","timestamp":1095792466000},"page":"609S-626S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"S","title":["Antithrombotic Therapy in Peripheral Arterial Occlusive Disease"],"prefix":"10.1016","volume":"126","author":[{"given":"G. Patrick","family":"Clagett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tangelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.3_suppl.609S_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.0954-6820.1982.tb01939.x","article-title":"Prevalence of intermittent claudication and its effect on mortality","volume":"211","author":"Reunanen","year":"1982","journal-title":"Acta Med Scand"},{"key":"10.1378\/chest.126.3_suppl.609S_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.293.6555.1137","article-title":"Fate in intermittent claudication: outcome and risk factors","volume":"293","author":"Jelnes","year":"1986","journal-title":"BMJ"},{"key":"10.1378\/chest.126.3_suppl.609S_bib3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0950-821X(05)80262-2","article-title":"Prevalence of symptomatic leg ischaemia in a Swedish community: an epidemiological study","volume":"7","author":"Skau","year":"1993","journal-title":"Eur J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/01.CIR.71.3.510","article-title":"The prevalence of peripheral arterial disease in a defined population","volume":"71","author":"Criqui","year":"1985","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.88.3.837","article-title":"Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study","volume":"88","author":"Newman","year":"1993","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0741-5214(93)90021-D","article-title":"Nonoperative treatment of superficial femoral artery disease: long-term follow-up","volume":"17","author":"Cox","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archsurg.1984.01390160060012","article-title":"Intermittent claudication","volume":"119","author":"Cronenwett","year":"1984","journal-title":"Arch Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0741-5214(89)70041-0","article-title":"Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study","volume":"9","author":"Howell","year":"1989","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib9","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0140-6736(93)92123-B","article-title":"Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis","volume":"342","author":"Ogren","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib10","doi-asserted-by":"crossref","unstructured":"Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev (database online). Issue 2, 2000","DOI":"10.1002\/14651858.CD000990"},{"key":"10.1378\/chest.126.3_suppl.609S_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9343(01)01034-8","article-title":"Current medical therapies for patients with peripheral arterial disease: a critical review","volume":"112","author":"Regensteiner","year":"2002","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib12","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication","volume":"344","author":"Hiatt","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1378\/chest.126.3_suppl.609S_bib14","first-page":"416","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: a prospective double-blind arterio-graphically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib15","first-page":"59","article-title":"Treatment of claudication with dipyridamole and aspirin","volume":"6","author":"Libretti","year":"1986","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1378\/chest.126.3_suppl.609S_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/030006059001800508","article-title":"Treatment of intermittent claudication with antiplatelet agents","volume":"18","author":"Giansante","year":"1990","journal-title":"J Int Med Res"},{"key":"10.1378\/chest.126.3_suppl.609S_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0140-6736(92)93216-A","article-title":"Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study","volume":"340","author":"Goldhaber","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-0038-1646882","article-title":"Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs?","volume":"62","author":"Boissel","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.609S_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2007-1002700","article-title":"Ticlopidine in the treatment of peripheral occlusive arterial disease","volume":"15","author":"Arcan","year":"1989","journal-title":"Semin Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.609S_bib20","first-page":"84","article-title":"Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial","volume":"114","author":"Balsano","year":"1989","journal-title":"J Lab Clin Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1078-5884(05)80200-X","article-title":"Reduction of the requirement for leg vascular surgery during long-term treatment of claudicant patients with ticlopidine: results from the Swedish Ticlopidine Multicentre Study (STIMS)","volume":"10","author":"Bergqvist","year":"1995","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0741-5214(98)70357-X","article-title":"Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease","volume":"27","author":"Money","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.CIR.98.7.678","article-title":"Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial","volume":"98","author":"Dawson","year":"1998","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9610(99)00147-6","article-title":"The effect of withdrawal of drugs treating intermittent claudication","volume":"178","author":"Dawson","year":"1999","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib26","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacologic treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0002-9343(00)00569-6","article-title":"A comparison of cilostazol and pentoxifylline for treating intermittent claudication","volume":"109","author":"Dawson","year":"2000","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1185\/03007997909109432","article-title":"Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease","volume":"6","author":"Angelkort","year":"1979","journal-title":"Curr Med Res Opin"},{"key":"10.1378\/chest.126.3_suppl.609S_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0741-5214(87)90029-2","article-title":"Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?","volume":"6","author":"Johnson","year":"1987","journal-title":"J Vasc Surg"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.609S_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00365518109097457","article-title":"Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease","volume":"156","author":"Angelkort","year":"1981","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1378\/chest.126.3_suppl.609S_bib31","first-page":"1053","article-title":"Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials","volume":"155","author":"Hood","year":"1996","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.126.3_suppl.609S_bib32","first-page":"557","article-title":"Double blind study of pentoxifylline against placebo in patients with intermittent claudication","volume":"1","author":"Bollinger","year":"1977","journal-title":"Pharmatherapeutica"},{"key":"10.1378\/chest.126.3_suppl.609S_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/000331978303400105","article-title":"Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication","volume":"34","author":"DiPerri","year":"1983","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/000331978403500702","article-title":"Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration","volume":"35","author":"Roekaerts","year":"1984","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib35","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/000331978403500709","article-title":"Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs","volume":"35","author":"Strano","year":"1984","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.80.6.1549","article-title":"Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease","volume":"80","author":"Lindgarde","year":"1989","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/000331979704800306","article-title":"A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly","volume":"48","author":"Ciocon","year":"1997","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0002-8703(82)90642-1","article-title":"Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients","volume":"104","author":"Porter","year":"1982","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3_suppl.609S_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0003319789040004010","article-title":"Acenocoumarol and pentoxifylline in intermittent claudication: a controlled clinical study: the APIC study group","volume":"40","author":"Dettori","year":"1989","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1445-5994.1985.tb02759.x","article-title":"Intermittent claudication: a double-blind crossover trial of pentoxifylline","volume":"15","author":"Gallus","year":"1985","journal-title":"Aust N Z J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib41","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/000331978403500605","article-title":"Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication","volume":"35","author":"Perhoniemi","year":"1984","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib42","first-page":"445","article-title":"A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects","volume":"100","author":"Reilly","year":"1987","journal-title":"N Z Med J"},{"issue":"suppl 1","key":"10.1378\/chest.126.3_suppl.609S_bib43","first-page":"126","article-title":"Treatment of circulatory disturbances with pentoxifylline: a double blind study with Trental","volume":"3","author":"Tonak","year":"1983","journal-title":"Pharmatherapeutica"},{"key":"10.1378\/chest.126.3_suppl.609S_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7326\/0003-4819-113-2-135","article-title":"Conservative management of intermittent claudication","volume":"113","author":"Radack","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib45","first-page":"79","article-title":"Peripheral artery disease","volume":"June","author":"Anand","year":"2002","journal-title":"Clin Evid"},{"key":"10.1378\/chest.126.3_suppl.609S_bib46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.81.2.602","article-title":"Benefit of exercise conditioning for patients with peripheral arterial disease","volume":"81","author":"Hiatt","year":"1990","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib47","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/01.CIR.95.9.2298","article-title":"Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1prodrug, in patients with intermittent claudication","volume":"95","author":"Belch","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib48","first-page":"160","article-title":"Efficacy of prostaglandin E1in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease: results of a prospective randomized, double-blind, multicenter clinical trial","volume":"1","author":"Schuler","year":"1984","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib49","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.CIR.90.2.818","article-title":"Intensive vascular training in stage IIb of peripheral arterial occlusive disease: the additive effects of intravenous prostaglandin E1or intravenous pentoxifylline during training","volume":"90","author":"Scheffler","year":"1994","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-130-5-199903020-00005","article-title":"Prostanoids for chronic critical leg ischemia: a randomized, controlled, open-label trial with prostaglandin E1","volume":"130","author":"The ICAI Study Group","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib51","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/01.CIR.95.9.2298","article-title":"Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E1 prodrug, in patients with intermittent claudication","volume":"95","author":"Belch","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib52","first-page":"369","article-title":"Prostacyclin treatment of ischemic ulcers and rest pain in unreconstructible peripheral arterial occlusive disease","volume":"100","author":"Cronenwett","year":"1986","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.609S_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0049-3848(85)90029-5","article-title":"Prostacyclin for ischemic ulcers in peripheral arterial disease: a random assignment, placebo controlled study","volume":"37","author":"Nizankowski","year":"1985","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.609S_bib54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(83)91625-2","article-title":"Epoprostenol (prostacyclin) and severe arterial disease: a double-blind study","volume":"1","author":"Belch","year":"1983","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/01.CIR.102.4.426","article-title":"Oral beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial","volume":"102","author":"Lievre","year":"2000","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib56","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/01.CIR.80.6.1544","article-title":"Randomized placebo-controlled, double-blind trial of ketanserin in claudicants: changes in claudication distance and ankle systolic pressure","volume":"80","author":"PACK Claudication Substudy Investigators","year":"1989","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00005344-198103000-00006","article-title":"Controlled trial of suloctidil in intermittent claudication","volume":"3","author":"Verhaeghe","year":"1981","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib58","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9610(05)81012-8","article-title":"Fish oil supplementation in patients with stable claudication","volume":"160","author":"Gans","year":"1990","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib59","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bjs.1800670515","article-title":"A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication","volume":"67","author":"Clyne","year":"1980","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/bjs.1800680414","article-title":"Naftidrofuryl for ischaemic rest pain: a controlled trial","volume":"68","author":"Greenhalgh","year":"1981","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib61","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/01.CIR.87.5.1563","article-title":"Effect of picotamide on the clinical progression of peripheral vascular disease: a double-blind placebo-controlled study","volume":"87","author":"Balsano","year":"1993","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib62","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/01.STR.26.4.597","article-title":"Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution: a two-year, double-blind, placebo-controlled study in diabetic patients","volume":"26","author":"Cocozza","year":"1995","journal-title":"Stroke"},{"key":"10.1378\/chest.126.3_suppl.609S_bib63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0037-1614560","article-title":"Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis","volume":"81","author":"Girolami","year":"1999","journal-title":"Thromb Haemost"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.609S_bib64","first-page":"27","article-title":"Hemodilution in peripheral arterial occlusive disease: placebo controlled randomized double-blind study with hydroxyethyl starch or dextran","volume":"18","author":"Ernst","year":"1991","journal-title":"Acta Med Austriaca"},{"key":"10.1378\/chest.126.3_suppl.609S_bib65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2796.1990.tb00127.x","article-title":"Haemodilution with medium molecular weight hydroxyethyl starch in patients with peripheral arterial occlusive disease stage IIb","volume":"227","author":"Kiesewetter","year":"1990","journal-title":"J Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib66","doi-asserted-by":"crossref","unstructured":"Cosmi B, Conti E, Coccheri S. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. Cochrane Database Syst Rev (database online). Issue 2, 2002","DOI":"10.1002\/14651858.CD001999"},{"key":"10.1378\/chest.126.3_suppl.609S_bib67","first-page":"833","article-title":"Arterial embolization: problems of source, multiplicity, recurrence, and delayed treatments","volume":"88","author":"Elliott","year":"1980","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.609S_bib68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9610(82)90196-9","article-title":"Arterial embolism: a 44-year perspective","volume":"143","author":"Abbott","year":"1982","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1051-0443(07)61877-6","article-title":"The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease","volume":"12","author":"Kasirajan","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s003300101014","article-title":"Percutaneous thrombectomy","volume":"12","author":"Morgan","year":"2002","journal-title":"Eur Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib71","first-page":"207","article-title":"Thrombolysis in the management of limb peripheral arterial occlusion: a consensus document","volume":"81","author":"Working Party on Thrombolysis in the Management of Limb Ischemia","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib72","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1051-0443(07)61419-5","article-title":"Initial results of reteplase in the treatment of acute lower extremity arterial occlusions","volume":"11","author":"Davidian","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S1051-0443(07)61799-0","article-title":"Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study","volume":"11","author":"Ouriel","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib74","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1148\/radiol.2213010400","article-title":"Peripheral artery occlusion: treatment with abciximab plus urokinase versus urokinase alone: a randomized pilot trial (the PROMPT study)","volume":"221","author":"Duda","year":"2001","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib75","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/bjs.1800780831","article-title":"Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis","volume":"78","author":"Berridge","year":"1991","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/radiology.175.1.2107563","article-title":"Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial","volume":"175","author":"Meyerovitz","year":"1990","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib77","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000658-199409000-00003","article-title":"Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial","volume":"220","author":"The STILE Investigators","year":"1994","journal-title":"Ann Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib78","first-page":"64","article-title":"Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions","volume":"23","author":"Schweizer","year":"1996","journal-title":"Eur J Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib79","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1051-0443(99)70196-X","article-title":"Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial","volume":"10","author":"Ouriel","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0950-821X(05)80239-7","article-title":"Surgical treatment versus thrombolysis in acute arterial occlusion: a randomized controlled study","volume":"6","author":"Nilsson","year":"1992","journal-title":"Eur J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0741-5214(94)70214-4","article-title":"A comparison of thrombolytic therapy with operative vascularization in the initial treatment of acute peripheral arterial ischemia","volume":"19","author":"Ouriel","year":"1994","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib82","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0741-5214(96)70067-8","article-title":"Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial","volume":"24","author":"Weaver","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9610(96)00129-8","article-title":"Results of prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts","volume":"172","author":"Comerota","year":"1996","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib84","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0741-5214(05)80036-9","article-title":"Thrombolysis or peripheral arterial surgery: phase I results","volume":"23","author":"Ouriel","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib85","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199804163381603","article-title":"A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs","volume":"338","author":"Ouriel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/ejvs.1999.0975","article-title":"A systematic review of intra-arterial thrombolytic therapy for lower-limb ischaemia","volume":"19","author":"Palfrayman","year":"2000","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib87","unstructured":"Berridge DC, Kessel D, Robertson I. Surgery versus thrombolysis for acute limb ischaemia: initial management. Cochrane Database Syst Rev (database online). Issue 3, 2002"},{"key":"10.1378\/chest.126.3_suppl.609S_bib88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/ejvs.2001.1438","article-title":"Patency following successful thrombolysis of occluded vascular grafts","volume":"22","author":"Galland","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0741-5214(86)90073-X","article-title":"Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions","volume":"3","author":"Veith","year":"1986","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib90","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0741-5214(90)90262-9","article-title":"Present status of reversed vein bypass grafting: five-year results of a modern series","volume":"11","author":"Taylor","year":"1990","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0741-5214(91)90211-C","article-title":"Prospective randomized multicenter comparison ofin situand reversed vein infrapopliteal bypasses","volume":"13","author":"Wengerter","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib92","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/bjs.1800700210","article-title":"A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery: preliminary results","volume":"70","author":"Eickhoff","year":"1983","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib93","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0950-821X(05)80177-X","article-title":"PTFE or HUV for femoro-popliteal bypass: a multi-centre trial","volume":"5","author":"McCollum","year":"1991","journal-title":"Eur J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib94","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0741-5214(92)90043-8","article-title":"Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial","volume":"16","author":"Aalders","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib95","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1078-5884(05)80218-7","article-title":"Pathophysiology of vein graft failure: a review","volume":"9","author":"Davies","year":"1995","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib96","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000658-197309000-00002","article-title":"Biologic fate of autogenous vein implants as arterial substitutes: clinical, angiographic and histopathologic observations in femoro-popliteal operations for atherosclerosis","volume":"178","author":"Szilagy","year":"1973","journal-title":"Ann Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib97","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00000658-198312000-00008","article-title":"Aspirin and dipyridamole reduced platelet deposition on prosthetic femoropopliteal grafts in man","volume":"198","author":"Goldman","year":"1983","journal-title":"Ann Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib98","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0002-9149(83)80136-2","article-title":"In vivoquantitation of platelet deposition on human peripheral arterial bypass grafts using indium-111-labeled platelets: effect of dipyridamole and aspirin","volume":"51","author":"Pumphrey","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib99","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.CIR.103.7.961","article-title":"Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials","volume":"103","author":"Chew","year":"2001","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1078-5884(96)80281-4","article-title":"Intraoperative heparinisation, blood loss and myocardial infarction during aortic aneurysm surgery: a joint vascular research group study","volume":"12","author":"Thompson","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib101","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0022-5223(19)34410-1","article-title":"Evaluation of patients at risk for protamine reactions","volume":"98","author":"Levy","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib102","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0741-5214(89)90055-4","article-title":"Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery","volume":"9","author":"Gupta","year":"1988","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJM198904063201402","article-title":"Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0741-5214(95)70137-0","article-title":"Protamine reversal during peripheral vascular surgery: a prospective randomized trial","volume":"22","author":"Dorman","year":"1995","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1078-5884(97)80082-2","article-title":"Should heparin be reversed after carotid endarterectomy? A randomised prospective trial","volume":"13","author":"Fearn","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib106","series-title":"Thrombosen, embolien und aggregationshemmer in der chirurgie","first-page":"68","article-title":"Klinische Anwendung von Aggregationshemmern bei arterieller Verschlusskrankheit","author":"Zekert","year":"1977"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.609S_bib107","doi-asserted-by":"crossref","first-page":"283S","DOI":"10.1378\/chest.119.1_suppl.283S","article-title":"Antithrombotic therapy in peripheral arterial occlusive disease","volume":"119","author":"Jackson","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.609S_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6922.159","article-title":"Collaborative overview of randomized trials of antiplatelet therapy: II. Maintenance of vascular graft or arterial patency by antiplatelet therapy","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1378\/chest.126.3_suppl.609S_bib109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0741-5214(99)70109-6","article-title":"Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery","volume":"30","author":"Tangelder","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0741-5214(91)90022-M","article-title":"Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial","volume":"13","author":"McCollum","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib111","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/153857448501900405","article-title":"The influence of platelet inhibition on the patency of femoro-popliteal dacron bypass grafts","volume":"19","author":"Donaldson","year":"1985","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib112","first-page":"1016","article-title":"Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency","volume":"92","author":"Green","year":"1982","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.609S_bib113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/153857448401800404","article-title":"A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts","volume":"18","author":"Goldman","year":"1984","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib114","first-page":"462","article-title":"Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts","volume":"96","author":"Kohler","year":"1984","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.609S_bib115","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/bjs.1800740406","article-title":"Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts","volume":"74","author":"Clyne","year":"1987","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib116","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2125.2000.00178.x","article-title":"Graft material and results of platelet inhibitor trials in peripheral arterial reconstructions: reappraisal of results from a meta-analysis","volume":"49","author":"Watson HR","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib117","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":"Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomized trial","volume":"355","author":"Dutch Bypass Oral Anticoagulants or Aspirin (BOA) Study Group","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib118","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJM199712113372404","article-title":"Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs","volume":"337","author":"Becquemin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib119","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.72.1.138","article-title":"Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery","volume":"72","author":"Brown","year":"1985","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib120","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/01.CIR.83.5.1526","article-title":"Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery","volume":"83","author":"Gavaghan","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib121","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.CIR.84.2.520","article-title":"Starting aspirin therapy after operation","volume":"84","author":"Goldman","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0735-1097(90)90168-O","article-title":"Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting","volume":"15","author":"Sethi","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib123","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archsurg.1992.01420090120018","article-title":"A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis","volume":"127","author":"Kretschmer","year":"1992","journal-title":"Arch Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib124","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0002-9610(06)80065-6","article-title":"Influence on coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery","volume":"159","author":"Arfvidsson","year":"1990","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib125","first-page":"73","article-title":"Medikament\u00f6se Rezidivprophilaxe nach fermoro-poplitealer Arterienrekonstruktion","volume":"2","author":"Schneider","year":"1979","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib126","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure","volume":"28","author":"Sarac","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib127","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","article-title":"Benefits, morbidity and mortality associated with long-term administration of oral anticoagulants to patients with peripheral arterial bypass procedures: a prospective randomized study","volume":"35","author":"Johnson","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib128","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mva.2001.111986","article-title":"Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery","volume":"33","author":"Tangelder","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib129","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(94)92269-1","article-title":"Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting","volume":"344","author":"Edmondson","year":"1994","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib130","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.STR.18.4.722","article-title":"Platelet deposition at carotid endarterectomy sites in humans","volume":"18","author":"Stratton","year":"1987","journal-title":"Stroke"},{"key":"10.1378\/chest.126.3_suppl.609S_bib131","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3171\/jns.1985.63.5.0693","article-title":"Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation","volume":"63","author":"Findlay","year":"1985","journal-title":"J Neurosurg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib132","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.STR.9.4.309","article-title":"Controlled trial of aspirin in cerebral ischemia: Part II. Surgical group","volume":"9","author":"Fields","year":"1978","journal-title":"Stroke"},{"key":"10.1378\/chest.126.3_suppl.609S_bib133","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.19.10.1211","article-title":"Danish very-low-dose aspirin after carotid endarterectomy trial","volume":"19","author":"Boysen","year":"1988","journal-title":"Stroke"},{"key":"10.1378\/chest.126.3_suppl.609S_bib134","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.STR.24.8.1125","article-title":"Does low-dose acetylsalicylic acid prevent stroke after carotid surgery? A double-blind, placebo-controlled randomized trial","volume":"24","author":"Lindblad","year":"1993","journal-title":"Stroke"},{"key":"10.1378\/chest.126.3_suppl.609S_bib135","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/S0140-6736(99)05388-X","article-title":"Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial","volume":"353","author":"Taylor","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.609S_bib136","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0741-5214(90)90046-D","article-title":"The influence of neutralizing heparin after carotid endarterectomy on postoperative stroke and wound hematoma","volume":"12","author":"Treiman","year":"1990","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib137","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0002-9610(84)90451-3","article-title":"Wound hematomas after carotid endarterectomy","volume":"148","author":"Kunkel","year":"1984","journal-title":"Am J Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib138","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0741-5214(92)90166-6","article-title":"Adverse effects of aspirin in the treatment of asymptomatic carotid artery stenosis","volume":"16","author":"Krupski","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib139","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0741-5214(93)90411-E","article-title":"Influence of aspirin in the management of asymptomatic carotid artery stenosis","volume":"17","author":"Hobson","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib140","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-123-9-199511010-00002","article-title":"Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing","volume":"123","author":"C\u00f4t\u00e9","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib141","series-title":"When should I reoperate for recurrent carotid stenosis? Naylor, AR Mackey, WC eds.Carotid artery surgery: a problem based approach","first-page":"375","author":"Clagett","year":"2002"},{"key":"10.1378\/chest.126.3_suppl.609S_bib142","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archsurg.1982.01380350016003","article-title":"Carotid artery stenosis following endarterectomy","volume":"117","author":"Zierler","year":"1982","journal-title":"Arch Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib143","first-page":"313","article-title":"Etiologic factors for recurrent carotid artery stenosis","volume":"93","author":"Clagett","year":"1983","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.609S_bib144","doi-asserted-by":"crossref","first-page":"731","DOI":"10.7326\/0003-4819-116-9-731","article-title":"Failure of aspirin plus dipyridamole to prevent restenosis after carotid endarterectomy","volume":"116","author":"Harker","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib145","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD): trans-Atlantic inter-societal consensus (TASC)","volume":"31","author":"TASC Working Group","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.609S_bib146","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1051-0443(07)61397-9","article-title":"PTA verus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study","volume":"12","author":"Cejna","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.609S_bib147","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/01.CIR.0000029746.10018.36","article-title":"Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results","volume":"106","author":"Duda","year":"2002","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib148","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.609S_bib149","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/000331979004100402","article-title":"Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA","volume":"41","author":"Heiss","year":"1990","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0950-821X(05)80126-4","article-title":"Platelet inhibition with ASA\/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease: a prospective double-blind trial","volume":"8","author":"Study Group on Pharmacological Treatment after PTA","year":"1994","journal-title":"Eur J Vasc Surg"},{"issue":"suppl 20","key":"10.1378\/chest.126.3_suppl.609S_bib151","first-page":"355","article-title":"Zur rezidivprophylaxe nach perkutaner transluminaler Angioplastie (PTA): Antikoagulation versus Ticlopidin","volume":"16","author":"Schneider","year":"1987","journal-title":"Vasa"},{"key":"10.1378\/chest.126.3_suppl.609S_bib152","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.CIR.83.1.141","article-title":"Nd: Yag laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions: long-term results","volume":"83","author":"Pilger","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.609S_bib153","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1148\/radiology.193.2.7972781","article-title":"Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty","volume":"193","author":"Do","year":"1994","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.609S_bib154","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A randomized trial comparing three drug regimens to prevent thrombosis following elective coronary stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215315063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215315063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:47:47Z","timestamp":1757918867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215315063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":154,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0012369215315063"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.609s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy in Peripheral Arterial Occlusive Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.609S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}